Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-26-058989
Filing Date
2026-05-19
Accepted
2026-05-19 16:01:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0291471-424b3_scinai.htm 424B3 338185
2 GRAPHIC ea029147101_img1.jpg GRAPHIC 5359
  Complete submission text file 0001213900-26-058989.txt   346932
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-295698 | Film No.: 26998485
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)